Boston, MA 03/19/2014 (wallstreetpr) – Tranzbyte Corp (OTCMKTS: ERBB) seems to be enjoying its best trading sessions in the market as its stock continues the rally that started last week. The surge in the market seem not to be stopping, with the company closing Tuesday active trading session 16% on the green. Traded volumes for Tuesday were high compared to the volumes experienced on Monday, week opening session.
Despite slightly dipping on Tuesday trading session the company’s stock rallied once again to climb to a high of $0.07 a share. Excitement cooled off after sometime although heavy volumes had pushed the price up in double digit numbers. The company’s stock is already surging in today’s intraday trading session at the back of the Company’s COO providing positive update on the ZaZZZ machine.
Mr. shearin was quoted as saying that the company’s ZaZZZ machine is still in production stage and once completed will be added to the company, but did not give any specific timeline when to expect this. Tranzbyte continues to be tight lipped on its last reported financials dating back in December 2013. The financials stand at $2 thousand in cash, $3 million in current liabilities, $86 thousand in quarterly revenues as well as $323 thousand in net loss.
Tranzbyte Slowly picking up
The past weeks have been bumpy for Tranzbyte which has been fluctuating at low margins of between $0.02 and $0.04. This week has seen the company rally by as much as 27% with volumes also picking up. The climb in the market has been attributed to the circulation of an image, of its proposed “Jurassic” oxygenations system that is being reported to have the ability of increasing the amount of oxygen that can dissolve in water.
According to unspecified studies, if the oxygenation system comes to pass, it is expected to result in substantial increase in growth. The unit could yet again face some harsh reception in the market considering it has a steep set up price of $11.7 million. This news comes at the back of Tranzbyte announcing that several successful tests had been carried out in California and that Altitude Organix division will begin official tests with bloom dispensaries.
